by | Mar 15, 2023 | Publications, Uncategorized
JCO Glob Oncol. 2023 Mar;9:e2200369. doi: 10.1200/GO.22.00369. ABSTRACT PURPOSE: Human T-lymphotropic virus type 1 (HTLV-1) is an endemic virus in Latin America that is directly linked to adult T-cell leukemia/lymphoma (ATL). Previous studies have suggested an...
by | Mar 15, 2023 | Publications, Uncategorized
Clin Hematol Int. 2023 Mar 15. doi: 10.1007/s44228-023-00032-y. Online ahead of print. ABSTRACT Adult T-cell leukemia/lymphoma (ATLL) remains challenging to treat and has dismal outcome. Allogeneic stem-cell transplantation (allo-SCT) has promising results, but data...
by | Mar 9, 2023 | Publications, Uncategorized
eNeurologicalSci. 2023 Feb 20;31:100453. doi: 10.1016/j.ensci.2023.100453. eCollection 2023 Jun. ABSTRACT A 78-year-old man developed paresthesias in the extremities. He was referred to our hospital because of positive anti-human T-cell leukemia virus type 1 (HTLV-1)...
by | Mar 6, 2023 | Publications, Uncategorized
Patterns (N Y). 2023 Feb 10;4(2):100674. doi: 10.1016/j.patter.2022.100674. eCollection 2023 Feb 10. ABSTRACT Human T-cell leukemia virus type 1 (HTLV-1), a retrovirus, is the causative agent for adult T cell leukemia/lymphoma and many other human diseases. Accurate...
by HTLV | Mar 3, 2023 | Publications
This workshop discussed “The Response to HTLV in the Framework of Maternal and Child Health” in the Americas. HTLV-1 impact is broad and significant, however, there are effective interventions to prevent transmission, particularly mother-to-child. Barriers that hamper...
by | Mar 2, 2023 | Publications, Uncategorized
Int J Hematol. 2023 Mar 2. doi: 10.1007/s12185-023-03572-4. Online ahead of print. ABSTRACT Adult T-cell leukemia-lymphoma (ATL) is classified into four clinical subtypes: acute, lymphoma, chronic, and smoldering. Chronic ATL is further divided into unfavorable and...
